Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years

Serotyping of Pneumococci

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00843895

Acronym

Pneumococci

Enrollment

400

Registered

2009-02-13

Start date

2009-03-31

Completion date

2009-12-31

Last updated

2009-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumococcal Disease

Keywords

Laboratory based study, antibiotic susceptibilty, invasive strains

Brief summary

The purpose of this study is to identify the S. pneumoniae serotypes strains and to determine antibiotic susceptibility.

Interventions

BIOLOGICALpneumococcal conjugate vaccine(prevenar)

to see the vaccine impact on pneumococcal diseases

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

3 Weeks to 5 Years

Healthy volunteers

Inclusion criteria

* age less than 5 years

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame
Incidence and serotypes of invasive pneumococcal dis.	6-8 months

Secondary

Measure	Time frame
Antibiotic susceptibility	6-8 months

Contacts

Primary ContactAtef M. Shibl, PH D

amshibl@ksu.edu.sa00966505 30 2775

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026